Skip to main content
. 2020 Jul 2;15:173. doi: 10.1186/s13023-020-01452-2

Fig. 4.

Fig. 4

Soluble CD163 in chronic Wilson’s disease patients treated with a chelating agent, zinc or both. Boxes represent interquartile ranges with medians, whiskers show upper and lower adjacent values and closed circles outside values. * P < 0.001 zinc vs. chelating agent. There were no other differences between groups